188 related articles for article (PubMed ID: 18675784)
1. A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities.
Dong Q; Chan HL; Liu Z; Chan DP; Zhang B; Chen Y; Kung HF; Sung JJ; He ML
Biochem Biophys Res Commun; 2008 Oct; 374(4):773-6. PubMed ID: 18675784
[TBL] [Abstract][Full Text] [Related]
2. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
3. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
[TBL] [Abstract][Full Text] [Related]
4. A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma.
Liu S; Xie J; Yin J; Zhang H; Zhang Q; Pu R; Li C; Ni W; Wang H; Cao G
J Med Virol; 2011 Jan; 83(1):45-53. PubMed ID: 21108338
[TBL] [Abstract][Full Text] [Related]
5. Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: story beyond A1762T/G1764A mutations.
Liu CJ; Kao JH
J Gastroenterol Hepatol; 2008 Mar; 23(3):347-50. PubMed ID: 18318819
[No Abstract] [Full Text] [Related]
6. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications.
Yuan J; Zhou B; Tanaka Y; Kurbanov F; Orito E; Gong Z; Xu L; Lu J; Jiang X; Lai W; Mizokami M
J Clin Virol; 2007 Jun; 39(2):87-93. PubMed ID: 17451999
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
[TBL] [Abstract][Full Text] [Related]
8. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia.
Bahri O; Cheikh I; Hajji N; Djebbi A; Maamouri N; Sadraoui A; Mami NB; Triki H
J Med Virol; 2006 Mar; 78(3):353-7. PubMed ID: 16419125
[TBL] [Abstract][Full Text] [Related]
11. Core promoter mutations (A(1762)T and G(1764)A) and viral genotype in chronic hepatitis B and hepatocellular carcinoma in Guangxi, China.
Fang ZL; Yang J; Ge X; Zhuang H; Gong J; Li R; Ling R; Harrison TJ
J Med Virol; 2002 Sep; 68(1):33-40. PubMed ID: 12210428
[TBL] [Abstract][Full Text] [Related]
12. In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter.
Laras A; Koskinas J; Hadziyannis SJ
Virology; 2002 Mar; 295(1):86-96. PubMed ID: 12033768
[TBL] [Abstract][Full Text] [Related]
13. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
Guo X; Jin Y; Qian G; Tu H
J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
[TBL] [Abstract][Full Text] [Related]
14. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.
Yuen MF; Tanaka Y; Shinkai N; Poon RT; But DY; Fong DY; Fung J; Wong DK; Yuen JC; Mizokami M; Lai CL
Gut; 2008 Jan; 57(1):98-102. PubMed ID: 17483190
[TBL] [Abstract][Full Text] [Related]
15. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea.
Song BC; Kim H; Kim SH; Cha CY; Kook YH; Kim BJ
J Med Virol; 2005 Jan; 75(1):13-9. PubMed ID: 15543574
[TBL] [Abstract][Full Text] [Related]
16. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma.
Bläckberg J; Kidd-Ljunggren K
J Med Virol; 2003 Sep; 71(1):18-23. PubMed ID: 12858404
[TBL] [Abstract][Full Text] [Related]
17. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 Sep; 194(5):594-9. PubMed ID: 16897657
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
Lin CL; Kao JH
J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
[TBL] [Abstract][Full Text] [Related]
19. Genotype and variations in core promoter and pre-core regions are related to progression of disease in HBV-infected patients from Northern Vietnam.
Truong BX; Seo Y; Yano Y; Ho PT; Phuong TM; Long DV; Son NT; Long NC; Kato H; Hayashi Y; Trach NK; Kasuga M
Int J Mol Med; 2007 Feb; 19(2):293-9. PubMed ID: 17203204
[TBL] [Abstract][Full Text] [Related]
20. Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.
Araujo OC; Barros JJ; do Ó KM; Nabuco LC; Luz CA; Perez RM; Niel C; Villela-Nogueira CA; Araujo NM
J Med Virol; 2014 Feb; 86(2):217-23. PubMed ID: 24338810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
